Close
ACHEMA MIDDLE EAST 2026
LogiPharma 2026

Manufacturing

      Lonza and Ankyra Therapeutics Sign Agreement to Develop and Manufacture a Cytokine Fusion Protein

      Drug Development
      Ankyra Therapeutics, a biotechnology company developing cancer therapies based on localized cytokines that prime a systemic adaptive immune response, and Lonza announced a collaboration...

      Catalent Acquires Additional Facility at its Gosselies, Belgium Campus for Commercial-Scale Plasmid DNA Manufacturing

      Manufacturing
      Catalent, the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products,...

      Zydus Cadila gets EUA from DCGI for hepatitis drug Virafin to treat COVID-19

      Manufacturing
      Zydus Cadila has received restricted emergency use approval from the DCGI for the use of Pegylated Interferon alpha-2b (PegIFN) in treating moderate COVID-19 infection...

      RDIF and Minapharm Agree to Produce over 40 Million Doses of the Sputnik V Vaccine in Egypt

      Europe
      The Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund), Egypt’s Minapharm, the regional leader in recombinant DNA technology, and its Berlin-based subsidiary ProBioGen...

      Lonza Announces Construction of a New Small Molecule Manufacturing Complex in Visp

      Drug Development
      Lonza, a CDMO partner to the biopharma industry, announced the construction of a new small molecule manufacturing complex at its Visp (CH) site. The...

      MaxiVAX and Minaris Regenerative Medicine Enter into a Manufacturing Partnership for MVX-ONCO-2 Cancer Immunotherapy

      Manufacturing
      MaxiVAX SA, a private Swiss clinical-stage biotech company developing novel anti-cancer vaccines, and Minaris Regenerative Medicine GmbH, a leading contract development and manufacturing service...

      Evonik strengthens strategic partnership with BioNTech on COVID-19 vaccine

      Manufacturing
      Evonik is investing in the short-term expansion of its specialty lipids production which are essential for mRNA-based COVID-19 vaccines. Commercial lipid quantities are to...

      Subscribe Our Newsletter

      White Papers

      The Future of Digital Health

      Whitepapers 0
      The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....

      Five Best Practices to Deliver Exceptional Multichannel Experiences

      Whitepapers 0
      A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...

      The Impact and Use of Social Media in Pharmacovigilance

      Whitepapers 0
      Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...

      About us

      Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

      System

      Resources

      Subscribe

      © 2025 Copyright © Valuemediaservices 2025 All rights reserved.